Cardiomyopathy Related to a Weight Loss Supplement: A Case Report and Review of Literature

1Citations
Citations of this article
11Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

There are various etiologies of dilated cardiomyopathy. However, in young patients without a strong family history of cardiovascular disease, alcohol or drug abuse, viral infections, and absence of endocrine and metabolic abnormalities, ischemia is an unlikely cause. We present an interesting case of a young female without traditional risk factors who developed dilated cardiomyopathy following administration of a weight loss supplement xenadrine and had resolution of symptoms after discontinuation of the supplement.

Cite

CITATION STYLE

APA

Murtaza, G., Adhikari, S., Siddiqui, I., Lu, H., & Kuruvilla, A. (2017). Cardiomyopathy Related to a Weight Loss Supplement: A Case Report and Review of Literature. Journal of Investigative Medicine High Impact Case Reports, 5(2). https://doi.org/10.1177/2324709617711462

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free